The Journal of Thoracic and Cardiovascular Surgery
Volume 133, Issue 6 , Pages 1581-1587.e6 , June 2007

Beck and back: A paradigm change in coronary sinus interventions—pulsatile stretch on intact coronary venous endothelium

  • Guenter Weigel, MD

      Affiliations

    • Department of Cardiothoracic Surgery, Medical University of Vienna, Vienna, Austria
    • ,
  • Ilinka Kajgana, PhD

      Affiliations

    • TU BioMed, University of Technology, Vienna, Austria
    • ,
  • Helga Bergmeister, MD, DVM

      Affiliations

    • Institute of Biomedical Research, Medical University of Vienna, Vienna, Austria
    • ,
  • Gunther Riedl, MD

      Affiliations

    • Department of Cardiothoracic Surgery, Medical University of Vienna, Vienna, Austria
    • ,
  • Helmut-Dietmar Glogar, MD

      Affiliations

    • Department of Internal Medicine 2, Division of Cardiology, Medical University of Vienna, Vienna, Austria
    • ,
  • Mariann Gyöngyösi, MD

      Affiliations

    • Department of Internal Medicine 2, Division of Cardiology, Medical University of Vienna, Vienna, Austria
    • ,
  • Stefan Blasnig

      Affiliations

    • Carinthia University of Applied Sciences, Medical Information Technology, Klagenfurt, Austria.
    • ,
  • Georg Heinze, PhD

      Affiliations

    • Core Unit for Medical Statistics and Informatics, Section of Clinical Biometrics, Medical University of Vienna, Vienna, Austria
    • ,
  • Werner Mohl, MD, PhD

      Affiliations

    • Department of Cardiothoracic Surgery, Medical University of Vienna, Vienna, Austria
    • Corresponding Author InformationAddress for reprints: Werner Mohl, MD, PhD, Medical University of Vienna, Department of Cardiothoracic Surgery, Waehringer Guertel 18-20, 1090 Vienna, Austria.
    • Werner Mohl reports patents on PICSO.

Received 22 July 2006 ,Revised 20 November 2006 ,Accepted 28 December 2006.

References 

  1. Komamura K, Mishima M, Kodama K. Preliminary clinical experience with intermittent coronary sinus occlusion in combination with thrombolytic therapy in acute myocardial infarction. Jpn Circ J. 1989;53:1152–1163
  2. Nishida T, Shimokawa H, Oi K, Tatewaki H, Uwatoku T, Abe K, et al. Extracorporeal cardiac shock wave therapy markedly ameliorates ischemia-induced myocardial dysfunction in pigs in vivo. Circulation. 2004;110:3055–3061
  3. Kanamori T, Watanabe G, Yasuda T, Nagamine H, Kamiya H, Koshida Y. Hybrid surgical angiogenesis omentopexy can enhance myocardial angiogenesis induced by cell therapy. Ann Thorac Surg. 2006;81:160–168
  4. O Shaughnessy L. Experimental methods of providing collateral circulation to the heart. Br J Surg. 1936;23:665–670
  5. Syeda B, Schukro C, Heinze G, Modaressi K, Glogar D, Maurer G, et al. The salvage potential of coronary sinus interventions: meta-analysis and pathophysiologic consequences. J Thorac Cardiovasc Surg. 2004;127:1703–1712
  6. Hahn RS, Kim M. Revascularization of the heart (Histologic changes after arterialization of the coronary sinus). Circulation. 1952;5:810–815
  7. Pearson H. The heart of the matter. Nat Med. 2004;10:445–446
  8. Helmke BP. Molecular control of cytoskeletal mechanics by hemodynamic forces. Physiology (Bethesda). 2005;20:43–53
  9. Li S, Huang NF, Hsu S. Mechanotransduction in endothelial cell migration. J Cell Biochem. 2005;96:1110–1126
  10. Heil M, Schaper W. Influence of mechanical, cellular, and molecular factors on collateral artery growth (arteriogenesis). Circ Res. 2004;95:449–458
  11. Li J, Hampton T, Morgan JP, Simons M. Stretch-induced VEGF expression in the heart. J Clin Invest. 1997;100:18–24
  12. Seko Y, Seko Y, Takahashi N, Shibuya M, Yazaki Y. Pulsatile stretch stimulates vascular endothelial growth factor (VEGF) secretion by cultured rat cardiac myocytes. Biochem Biophys Res Commun. 1999;254:462–465
  13. Matthews JNS, Altman DG, Campbell MJ, Royston P. Analysis of serial measurements in medical research. Br Med J. 1990;300:230–235
  14. Vickers AJ, Altman DG. Statistics notes: analysing controlled trials with baseline and follow up measurements. Br Med J. 2001;323:1123–1124
  15. Lazar HL. Advantages of pressure-controlled intermittent coronary sinus occlusion over left ventricle–powered coronary sinus retroperfusion. Ann Thorac Surg. 2001;71:402
  16. Lazar H. Coronary sinus retroperfusion: can forward progress still be achieved by using a backward technique?. J Thorac Cardiovasc Surg. 2004;127:1549–1552
  17. Dulak J, Motterlini R, Huk I, Pachinger O, Weidinger F, Jozkowicz A. Carbon monoxide and iron, by-products of heme oxygenase, modulate vascular endothelial growth factor synthesis in vascular smooth muscle cells. In:  Abraham NG editors. Physiology and pathology of heme oxygenase. New York: Kluwer; 2002;p. 97–107
  18. Otterbein LE, Soares MP, Yamashita K, Bach FH. Heme oxygenase-1: unleashing the protective properties of heme. Trends Immunol. 2003;24:449–455
  19. Otterbein LE, Bach FH, Alam J, Soares M, Lu HT, Wysk M, et al. Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nat Med. 2000;6:422–428
  20. Lakkisto P, Palojoki E, Bäcklund T, Saraste A, Tikkanen I, Voipio-Pulkki LM, et al. Expression of heme oxygenase-1 in response to myocardial infarction in rats. J Mol Cell Cardiol. 2002;34:1357–1365
  21. Yet SF, Perrella MA, Layne MD, Hsieh CM, Maemura K, Kobzik L, et al. Hypoxia induces severe right ventricular dilatation and infarction in heme oxygenase-1 null mice. J Clin Invest. 1999;103:R23–R29
  22. Józkowicz A, Huk I, Nigisch A, Weigel G, Dietrich W, Motterlini R, et al. Heme oxygenase and angiogenic activity of endothelial cells: stimulation by carbon monoxide, inhibition by tin protoporphyrin-IX. Antioxid Redox Signal. 2003;5:155–162
  23. Dulak J, Józkowicz A, Foresti R, Kasza A, Frick M, Huk I, et al. Heme oxygenase activity modulates vascular endothelial growth factor synthesis in vascular smooth muscle cells. Antioxid Redox Signal. 2002;4:229–238
  24. Józkowicz A, Huk I, Nigisch A, Weigel G, Weidinger F, Dulak J. Effect of prostaglandin-J2 on VEGF synthesis depends on the induction of heme oxygenase-1. Anioxid Redox Signal. 2002;4:577–585
  25. Deramaudt BM, Braunstein S, Remy P, Abraham NG. Gene transfer of human heme oxygenase into coronary endothelial cells potentially promotes angiogenesis. J Cell Biochem. 1998;68:121–127
  26. Wagner CT, Durante W, Christodoulides N, Hellums JD, Schafer AI. Hemodynamic forces induce the expression of heme oxygenase in cultured vascular smooth muscle cells. J Clin Invest. 1997;100:589–596
  27. Bussolati B, Ahmed A, Pemberton H, Landis RC, Di Carlo F, Haskard DO, et al. Bifunctional role for VEGF-induced heme oxygenase-1 in vivo: induction of angiogenesis and inhibition of leukocytic infiltration. Blood. 2004;103:761–766
  28. Sharma HS, Das DK, Verdouw PD. Enhanced expression and localization of heme oxygenase-1 during recovery phase of porcine stunned myocardium. Mol Cell Biochem. 1999;196:133–139
  29. Mohl W, Kajgana I, Bergmeister H, Rattay F. Intermittent pressure elevation of the coronary venous system as a method to protect ischemic myocardium. Interact Cardiovasc Thorac Surg. 2005;4:66–69
  30. Li J, Brown LF, Hibberd MG, Grossman JD, Morgan JP, Simons M. VEGF, flk-1, and flt-1 expression in a rat myocardial infarction model of angiogenesis. Am J Physiol. 1996;270:H1803–H1811
  31. Davies PF, Tripathi SC. Mechanical stress mechanisms and the cell (An endothelial paradigm). Circ Res. 1993;72:239–245
  32. Zheng W, Brown MD, Brock TA, Bjercke RJ, Tomanek RJ. Bradycardia-induced coronary angiogenesis is dependent on vascular endothelial growth factor. Circ Res. 1999;85:192–198
  33. Cellwave Study: Combined extracorporal shock wave therapy and intracoronary cell therapy in chronic ischemic myocardium. 2006;www.clinicaltrials.gov_ClinicalTrials.gov Identifier: NCT00326989
  34. Harken DE. Beck and back. In:  Mohl W,  Faxon D,  Wolner E editor. The Clinics of CSI (Reprinted in the Coronary Sinus Library, 2003). Vol 4:Society of Coronary Sinus Interventions; 2003;p. 3–12

 This work was supported by the “Fonds zur Foerderung der wissenschaftlichen Forschung P 13274-Med,” the “Society of Coronary Sinus Interventions,” the Federal Ministry of Traffic, Innovation and Technology (BMVIT) GZ609.637/0002-III/I2/2004, the Ludwig Boltzmann Institute for Cardiosurgical Research, and the Austrian Research Center Seibersdorf.

PII: S0022-5223(07)00152-3

doi: 10.1016/j.jtcvs.2006.12.044

The Journal of Thoracic and Cardiovascular Surgery
Volume 133, Issue 6 , Pages 1581-1587.e6 , June 2007

Article Tools

* Image Usage & Resolution